Author Archive: Jim Greenwood

Jim Greenwood

Jim joined BIO as President & CEO in 2005 after representing the eighth district of Pennsylvania in the U.S. House of Representatives for six terms.  He had worked with BIO while in Congress on stem cell research and other health issues, and has since learned so much about the many applications of the science in food and agriculture and in industrial and environmental biotechnology.

Due to its revolutionary research and development in issues ranging from feeding the world by increasing crop yields to healing the world with new medicines to providing cleaner sources of energy, Jim is a passionate champion for biotechnology. When visiting member companies, he is inspired by executives and scientists who are united in their mission to help patients, farmers and other consumers lead a better life.

Prior to Congress, Jim served in the Pennsylvania House of Representatives and Pennsylvania Senate for six years each.  He and his wife Tina live in historic Washington Crossing, Pennsylvania (where he has participated in the re-enactment of George Washington crossing the Delaware River on Christmas Day in 1776). He enjoys fishing, birding and scuba diving.

You can find him on Facebook at https://www.facebook.com/jamescgreenwood.

Latest Posts

Telling the Biotech Story at the BIO International Convention

convention-ribbon

The global event for biotechnology wrapped up last week at the Boston Convention & Exhibition Center in Boston, Mass. The event was a huge success, with a record 25,291 partnering meetings and hundreds of high-level speakers addressing critical global challenges and opportunities. More than 16,500 industry leaders from 49 states and 65 countries attended, yet again earning the title as the largest biotechnology event in the world. People are always asking for my perspective on our Convention, Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , ,

We Are BIO

Jim Greenwood

Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

2012 BIO International Convention Keynotes: Back to Basics

Jim Greenwood

The 2012 BIO International Convention is a few short weeks away, and we are looking forward to this opportunity to come together for connections and partnerships that will lead to tomorrow’s breakthroughs. The Keynote Luncheon panels are always a highlight of the Convention. This year in Boston we decided to focus on core issues facing the global biotech community with keynote speakers and panelists who will provide timely insights on the economic, policy and business Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

National Bioeconomy Blueprint

Jim Greenwood

Today, the White House released its National Bioeconomy Blueprint.  The Blueprint defines the bioeconomy as, “economic activity that is fueled by research and innovation in the biological sciences” and identifies the bioeconomy as a priority for the Obama Administration. BIO provided input and submitted ideas to the Administration after it announced the development of the Blueprint last Fall. While the Administration has largely been focused on advancing innovation in areas such as electronic devices, social Read More >

Jim's Corner  |  2 Comments  |  Email This Post
Tags: , , , , , ,

Bringing Hope to Patients

Jim Greenwood

No-one expected Hope Bartley to survive after she was born three months early. Thanks to extraordinary biotech medicine, she did. Alena Galan, age 14, is one of only a few thousand patients with a rare disease called MPS. Thanks to the hard work of leading biotech scientists and the approval of a new treatment, she now has a chance to lead a normal life. Lori Lober experienced the unthinkable when she was diagnosed with Stage Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,